Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $55.01 USD
Change Today -0.64 / -1.15%
Volume 570.6K
CPHD On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 04/20/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Thomas L. Gutshall

Co-Founder, Director and Member of Nominating & Governance Committee, Cepheid
AgeTotal Calculated CompensationThis person is connected to 33 board members in 3 different organizations across 5 different industries.

See Board Relationships
76$388,223

Background*

Mr. Thomas L. Gutshall is a Co-founder of Cepheid and served as its Chief Executive Officer from August 1996 to April 2002. Mr. Gutshall has more than 35 years of experience in specialty chemicals, pharmaceuticals and diagnostics. He served as a Consultant to CV Therapeutics Inc. from September 1996 to December 2002 and served as its President and Chief Operating Officer from January 1995 to September 1996. Mr. Gutshall served in executive level positions with Syntex ...

Read Full Background

Corporate Headquarters*

904 Caribbean Drive
Sunnyvale, California 94089

United States

Phone: 408-541-4191
Fax: 408-541-4192

Board Members Memberships*

Former Director
Director
Director
1994-N/A
Former Chairman of Nominating & Governance Committee, Chairman of Nominating & Governance Committee, Director and Member of Audit Committee
1996-Present
Co-Founder, Director and Member of Nominating & Governance Committee

Education*

BS
University of Delaware

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$56,750
Total Calculated Compensation$388,223
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CPHD:US $55.01 USD -0.64

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
William J. Welch M.B.A.Chief Executive Officer, President and Director
Sequenom Inc.
$400.0K
John A. Kraeutler Chairman of The Board, Chief Executive Officer and President
Meridian Bioscience, Inc.
$602.9K
Nachum Shamir Chief Executive Officer, President and Director
Luminex Corporation
$275.0K
Carlo Rosa Chief Executive Officer, General Manager and Executive Director
DiaSorin S.p.A.
€705.5K
Jong-Yoon Cheon Founder, Chief Executive Officer and Chief Technology Officer
Seegene, Inc.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CEPHEID INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.